Simplicity Wealth LLC Has $137,000 Position in Haleon plc (NYSE:HLN)

Simplicity Wealth LLC reduced its position in shares of Haleon plc (NYSE:HLN) by 10.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,347 shares of the company’s stock after selling 1,630 shares during the period. Simplicity Wealth LLC’s holdings in Haleon were worth $137,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Procyon Advisors LLC boosted its position in shares of Haleon by 41.3% during the fourth quarter. Procyon Advisors LLC now owns 230,240 shares of the company’s stock worth $2,196,000 after buying an additional 67,329 shares during the period. HighTower Advisors LLC boosted its position in shares of Haleon by 27.2% during the third quarter. HighTower Advisors LLC now owns 350,795 shares of the company’s stock worth $3,701,000 after buying an additional 74,970 shares during the period. Jane Street Group LLC boosted its position in shares of Haleon by 1,689.4% during the third quarter. Jane Street Group LLC now owns 264,977 shares of the company’s stock worth $2,803,000 after buying an additional 250,169 shares during the period. Chartwell Investment Partners LLC boosted its position in shares of Haleon by 107.8% during the third quarter. Chartwell Investment Partners LLC now owns 475,415 shares of the company’s stock worth $5,030,000 after buying an additional 246,594 shares during the period. Finally, Townsquare Capital LLC boosted its position in shares of Haleon by 29.8% during the third quarter. Townsquare Capital LLC now owns 475,618 shares of the company’s stock worth $5,032,000 after buying an additional 109,217 shares during the period. 6.67% of the stock is owned by institutional investors and hedge funds.

Haleon Price Performance

NYSE:HLN opened at $10.40 on Wednesday. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. The stock’s 50 day moving average price is $9.69 and its two-hundred day moving average price is $9.87. The firm has a market capitalization of $47.06 billion, a price-to-earnings ratio of 30.57, a P/E/G ratio of 2.82 and a beta of 0.25. Haleon plc has a 12-month low of $7.89 and a 12-month high of $10.80.

Haleon (NYSE:HLN) last released its quarterly earnings data on Thursday, February 27th. The company reported $0.05 earnings per share (EPS) for the quarter. The firm had revenue of $3.54 billion for the quarter, compared to analyst estimates of $3.38 billion. Haleon had a return on equity of 14.76% and a net margin of 10.85%. On average, analysts anticipate that Haleon plc will post 0.43 earnings per share for the current year.

Haleon Increases Dividend

The firm also recently disclosed a — dividend, which will be paid on Thursday, June 5th. Shareholders of record on Friday, April 25th will be paid a $0.1166 dividend. This is a positive change from Haleon’s previous — dividend of $0.05. The ex-dividend date is Friday, April 25th. This represents a yield of 1.6%. Haleon’s dividend payout ratio is currently 58.97%.

Analyst Ratings Changes

Several research analysts have recently weighed in on HLN shares. Hsbc Global Res cut Haleon from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 5th. Morgan Stanley cut Haleon from an “overweight” rating to an “equal weight” rating in a research report on Friday, January 10th. Sanford C. Bernstein cut Haleon from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 8th. HSBC reissued a “hold” rating on shares of Haleon in a research report on Wednesday, March 5th. Finally, Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of Haleon in a research report on Monday, March 3rd. Six investment analysts have rated the stock with a hold rating, two have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Haleon currently has an average rating of “Hold” and a consensus price target of $10.95.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.